Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

BlueSync Field Evaluation
BlueSync Field Evaluation
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Institutes of Orland0
mi
from
Orlando, FL
BlueSync Field Evaluation
BlueSync Field Evaluation
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Institutes of Orland0
mi
from
Orlando, FL
Click here to add this to my saved trials
BlueSync Field Evaluation
BlueSync Field Evaluation
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
BlueSync Field Evaluation
BlueSync Field Evaluation
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
BlueSync Field Evaluation
BlueSync Field Evaluation
Status: Enrolling
Updated:  12/31/1969
CentraCare
mi
from
Saint Cloud, MN
BlueSync Field Evaluation
BlueSync Field Evaluation
Status: Enrolling
Updated: 12/31/1969
CentraCare
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
BlueSync Field Evaluation
BlueSync Field Evaluation
Status: Enrolling
Updated:  12/31/1969
The Valley Hospital
mi
from
Ridgewood, NJ
BlueSync Field Evaluation
BlueSync Field Evaluation
Status: Enrolling
Updated: 12/31/1969
The Valley Hospital
mi
from
Ridgewood, NJ
Click here to add this to my saved trials
BlueSync Field Evaluation
BlueSync Field Evaluation
Status: Enrolling
Updated:  12/31/1969
Cone Health
mi
from
Greensboro, NC
BlueSync Field Evaluation
BlueSync Field Evaluation
Status: Enrolling
Updated: 12/31/1969
Cone Health
mi
from
Greensboro, NC
Click here to add this to my saved trials
BlueSync Field Evaluation
BlueSync Field Evaluation
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
BlueSync Field Evaluation
BlueSync Field Evaluation
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
BlueSync Field Evaluation
BlueSync Field Evaluation
Status: Enrolling
Updated:  12/31/1969
Mount Carmel
mi
from
Columbus, OH
BlueSync Field Evaluation
BlueSync Field Evaluation
Status: Enrolling
Updated: 12/31/1969
Mount Carmel
mi
from
Columbus, OH
Click here to add this to my saved trials
BlueSync Field Evaluation
BlueSync Field Evaluation
Status: Enrolling
Updated:  12/31/1969
East Tennessee Consultants
mi
from
Knoxville, TN
BlueSync Field Evaluation
BlueSync Field Evaluation
Status: Enrolling
Updated: 12/31/1969
East Tennessee Consultants
mi
from
Knoxville, TN
Click here to add this to my saved trials
BlueSync Field Evaluation
BlueSync Field Evaluation
Status: Enrolling
Updated:  12/31/1969
CHU Bordeaux
mi
from
Bordeaux,
BlueSync Field Evaluation
BlueSync Field Evaluation
Status: Enrolling
Updated: 12/31/1969
CHU Bordeaux
mi
from
Bordeaux,
Click here to add this to my saved trials
The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia
The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia
Status: Enrolling
Updated:  12/31/1969
University of Texas at Austin Human Performance Laboratory
mi
from
Austin, TX
The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia
The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia
Status: Enrolling
Updated: 12/31/1969
University of Texas at Austin Human Performance Laboratory
mi
from
Austin, TX
Click here to add this to my saved trials
Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis
RADiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis
Status: Enrolling
Updated:  12/31/1969
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis
RADiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis
Status: Enrolling
Updated: 12/31/1969
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis
RADiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis
Status: Enrolling
Updated:  12/31/1969
The Lindner Clinical Trial Center
mi
from
Cincinnati, OH
Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis
RADiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis
Status: Enrolling
Updated: 12/31/1969
The Lindner Clinical Trial Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Increasing Exercise Capacity of Patients With Heart Failure by Wii Gaming
Increasing Exercise Capacity of Patients With Heart Failure by Wii Gaming (HF-Wii) A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
University of California
mi
from
Irvine, CA
Increasing Exercise Capacity of Patients With Heart Failure by Wii Gaming
Increasing Exercise Capacity of Patients With Heart Failure by Wii Gaming (HF-Wii) A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
University of California
mi
from
Irvine, CA
Click here to add this to my saved trials
Increasing Exercise Capacity of Patients With Heart Failure by Wii Gaming
Increasing Exercise Capacity of Patients With Heart Failure by Wii Gaming (HF-Wii) A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Center of Internal Medicine Elsterwerda
mi
from
Elsterwerda,
Increasing Exercise Capacity of Patients With Heart Failure by Wii Gaming
Increasing Exercise Capacity of Patients With Heart Failure by Wii Gaming (HF-Wii) A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Center of Internal Medicine Elsterwerda
mi
from
Elsterwerda,
Click here to add this to my saved trials
ConnectedHeartHealth - Heart Failure Readmission Intervention
ConnectedHeartHealth - Heart Failure Readmission Intervention
Status: Enrolling
Updated:  12/31/1969
Sinai Hospital of Baltimore
mi
from
Baltimore, MD
ConnectedHeartHealth - Heart Failure Readmission Intervention
ConnectedHeartHealth - Heart Failure Readmission Intervention
Status: Enrolling
Updated: 12/31/1969
Sinai Hospital of Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery
The Use of Desirudin Versus Heparin for Thrombosis Prophylaxis in Cardiothoracic Surgery Patients
Status: Enrolling
Updated:  12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery
The Use of Desirudin Versus Heparin for Thrombosis Prophylaxis in Cardiothoracic Surgery Patients
Status: Enrolling
Updated: 12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)
A Multicenter Open-Label Extension (OLE) Study To Assess The Long-Term Safety and Efficacy of Bempedoic Acid (ETC-1002) 180 MG
Status: Enrolling
Updated:  12/31/1969
Jedidiah Clinical Research
mi
from
Tampa, FL
Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)
A Multicenter Open-Label Extension (OLE) Study To Assess The Long-Term Safety and Efficacy of Bempedoic Acid (ETC-1002) 180 MG
Status: Enrolling
Updated: 12/31/1969
Jedidiah Clinical Research
mi
from
Tampa, FL
Click here to add this to my saved trials
Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)
A Multicenter Open-Label Extension (OLE) Study To Assess The Long-Term Safety and Efficacy of Bempedoic Acid (ETC-1002) 180 MG
Status: Enrolling
Updated:  12/31/1969
L-MARC Research Center
mi
from
Louisville, KY
Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)
A Multicenter Open-Label Extension (OLE) Study To Assess The Long-Term Safety and Efficacy of Bempedoic Acid (ETC-1002) 180 MG
Status: Enrolling
Updated: 12/31/1969
L-MARC Research Center
mi
from
Louisville, KY
Click here to add this to my saved trials
Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)
A Multicenter Open-Label Extension (OLE) Study To Assess The Long-Term Safety and Efficacy of Bempedoic Acid (ETC-1002) 180 MG
Status: Enrolling
Updated:  12/31/1969
Sentral Clinical Research Services, LLC
mi
from
Cincinnati, OH
Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)
A Multicenter Open-Label Extension (OLE) Study To Assess The Long-Term Safety and Efficacy of Bempedoic Acid (ETC-1002) 180 MG
Status: Enrolling
Updated: 12/31/1969
Sentral Clinical Research Services, LLC
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe
A Study in Patients With Chorioretinal Vascular Disease to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe
Status: Enrolling
Updated:  12/31/1969
Regeneron Study Site
mi
from
Houston, TX
Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe
A Study in Patients With Chorioretinal Vascular Disease to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe
Status: Enrolling
Updated: 12/31/1969
Regeneron Study Site
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe
A Study in Patients With Chorioretinal Vascular Disease to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
The Woodlands, TX
Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe
A Study in Patients With Chorioretinal Vascular Disease to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
An Open-Label, Randomized, Two-Treatment, Two-Sequence, Four-Period, Fully Replicated Crossover Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
Bio-Kinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
An Open-Label, Randomized, Two-Treatment, Two-Sequence, Four-Period, Fully Replicated Crossover Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Bio-Kinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Click here to add this to my saved trials
Aspirin and Enoxaparin for VTE in Trauma
The Role Of Combined Therapy With Aspirin and Enoxaparin In Prevention Of Venous Thromboembolism In Trauma Patients: A Randomized-Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Ryder Trauma Center
mi
from
Miami, FL
Aspirin and Enoxaparin for VTE in Trauma
The Role Of Combined Therapy With Aspirin and Enoxaparin In Prevention Of Venous Thromboembolism In Trauma Patients: A Randomized-Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Ryder Trauma Center
mi
from
Miami, FL
Click here to add this to my saved trials
Hold Parameters on Likely Cardiovascular Depressant Medications
Hold Parameters on Likely Cardiovascular Depressant Medications (HOLD)
Status: Enrolling
Updated:  12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Hold Parameters on Likely Cardiovascular Depressant Medications
Hold Parameters on Likely Cardiovascular Depressant Medications (HOLD)
Status: Enrolling
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Cardiac Monitor Employee Study
Cardiac Monitor Employee Study
Status: Enrolling
Updated:  12/31/1969
Boston Scientific
mi
from
Saint Paul, MN
Cardiac Monitor Employee Study
Cardiac Monitor Employee Study
Status: Enrolling
Updated: 12/31/1969
Boston Scientific
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Real Time Myocardial Contrast Echocardiography and Dobutamine Stress Perfusion Magnetic Resonance Imaging
Quantification of Ventricular Mechanics/Myocardial Blood Flow Reserve in Adolescents and Adults Ages 12-50 With Congenital or Acquired Heart Disease Using Bicycle Stress With Real Time Myocardial Contrast Echo and Dobutamine Stress MRI
Status: Enrolling
Updated:  12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Real Time Myocardial Contrast Echocardiography and Dobutamine Stress Perfusion Magnetic Resonance Imaging
Quantification of Ventricular Mechanics/Myocardial Blood Flow Reserve in Adolescents and Adults Ages 12-50 With Congenital or Acquired Heart Disease Using Bicycle Stress With Real Time Myocardial Contrast Echo and Dobutamine Stress MRI
Status: Enrolling
Updated: 12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Iron Deficiency and FGF23 Regulation in CKD and HF
Iron Deficiency and Fibroblast Growth Factor 23 Regulation in Chronic Kidney Disease and Heart Failure
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Iron Deficiency and FGF23 Regulation in CKD and HF
Iron Deficiency and Fibroblast Growth Factor 23 Regulation in Chronic Kidney Disease and Heart Failure
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
The Effect of Anesthesia on Neurodevelopmental Outcome (NDO)
Anesthesia and the Developing Brain: a Comparison of Two Anesthetic Techniques
Status: Enrolling
Updated:  12/31/1969
Stanford Children's Hospital
mi
from
Palo Alto, CA
The Effect of Anesthesia on Neurodevelopmental Outcome (NDO)
Anesthesia and the Developing Brain: a Comparison of Two Anesthetic Techniques
Status: Enrolling
Updated: 12/31/1969
Stanford Children's Hospital
mi
from
Palo Alto, CA
Click here to add this to my saved trials
HVNI Ambulation Feasibility Study
Assessing Clinical Effect of HVNI on Patient Ambulation in Acute Care Scenarios: a Feasibility Study
Status: Enrolling
Updated:  12/31/1969
Midwest Chest Consultants PC
mi
from
Saint Charles, MO
HVNI Ambulation Feasibility Study
Assessing Clinical Effect of HVNI on Patient Ambulation in Acute Care Scenarios: a Feasibility Study
Status: Enrolling
Updated: 12/31/1969
Midwest Chest Consultants PC
mi
from
Saint Charles, MO
Click here to add this to my saved trials
HVNI Ambulation Feasibility Study
Assessing Clinical Effect of HVNI on Patient Ambulation in Acute Care Scenarios: a Feasibility Study
Status: Enrolling
Updated:  12/31/1969
Knox Community Hospital
mi
from
Mount Vernon, OH
HVNI Ambulation Feasibility Study
Assessing Clinical Effect of HVNI on Patient Ambulation in Acute Care Scenarios: a Feasibility Study
Status: Enrolling
Updated: 12/31/1969
Knox Community Hospital
mi
from
Mount Vernon, OH
Click here to add this to my saved trials
HVNI Ambulation Feasibility Study
Assessing Clinical Effect of HVNI on Patient Ambulation in Acute Care Scenarios: a Feasibility Study
Status: Enrolling
Updated:  12/31/1969
Riverside Regional Medical Center
mi
from
Newport News, VA
HVNI Ambulation Feasibility Study
Assessing Clinical Effect of HVNI on Patient Ambulation in Acute Care Scenarios: a Feasibility Study
Status: Enrolling
Updated: 12/31/1969
Riverside Regional Medical Center
mi
from
Newport News, VA
Click here to add this to my saved trials
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated:  12/31/1969
Vascular Breakthroughs
mi
from
Darien, CT
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated: 12/31/1969
Vascular Breakthroughs
mi
from
Darien, CT
Click here to add this to my saved trials
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated:  12/31/1969
Yale University
mi
from
New Haven, CT
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated: 12/31/1969
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated:  12/31/1969
Midwest Cardiovascular Research Foundation
mi
from
Davenport, IA
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated: 12/31/1969
Midwest Cardiovascular Research Foundation
mi
from
Davenport, IA
Click here to add this to my saved trials
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated:  12/31/1969
Metro Health Hospital
mi
from
Wyoming, MI
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated: 12/31/1969
Metro Health Hospital
mi
from
Wyoming, MI
Click here to add this to my saved trials
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated:  12/31/1969
Cox Medical Centers
mi
from
Springfield, MO
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated: 12/31/1969
Cox Medical Centers
mi
from
Springfield, MO
Click here to add this to my saved trials
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated:  12/31/1969
North Carolina Heart and Vascular
mi
from
Raleigh, NC
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated: 12/31/1969
North Carolina Heart and Vascular
mi
from
Raleigh, NC
Click here to add this to my saved trials
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated:  12/31/1969
Cardiothoracic & Vascular Surgeons
mi
from
Austin, TX
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated: 12/31/1969
Cardiothoracic & Vascular Surgeons
mi
from
Austin, TX
Click here to add this to my saved trials
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated:  12/31/1969
Centra Health, Inc. dba Stroobants Cardiovascular Center
mi
from
Lynchburg, VA
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated: 12/31/1969
Centra Health, Inc. dba Stroobants Cardiovascular Center
mi
from
Lynchburg, VA
Click here to add this to my saved trials
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated:  12/31/1969
Sentara Medical Group
mi
from
Virginia Beach, VA
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated: 12/31/1969
Sentara Medical Group
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated:  12/31/1969
Lake Washington Vascular, Pllc
mi
from
Bellevue, WA
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated: 12/31/1969
Lake Washington Vascular, Pllc
mi
from
Bellevue, WA
Click here to add this to my saved trials
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated:  12/31/1969
CAMC Health Education and Research Institute
mi
from
Charleston, WV
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated: 12/31/1969
CAMC Health Education and Research Institute
mi
from
Charleston, WV
Click here to add this to my saved trials
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated:  12/31/1969
Royal Prince Alfred Hospital
mi
from
Camperdown,
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
Status: Enrolling
Updated: 12/31/1969
Royal Prince Alfred Hospital
mi
from
Camperdown,
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Small Vessel Sub-trial
Status: Enrolling
Updated:  12/31/1969
Bakersfield Memorial Hospital
mi
from
Bakersfield, CA
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Small Vessel Sub-trial
Status: Enrolling
Updated: 12/31/1969
Bakersfield Memorial Hospital
mi
from
Bakersfield, CA
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Small Vessel Sub-trial
Status: Enrolling
Updated:  12/31/1969
MediQuest Research at Munroe Regional Medical Center
mi
from
Ocala, FL
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Small Vessel Sub-trial
Status: Enrolling
Updated: 12/31/1969
MediQuest Research at Munroe Regional Medical Center
mi
from
Ocala, FL
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Small Vessel Sub-trial
Status: Enrolling
Updated:  12/31/1969
Florida Hospital
mi
from
Orlando, FL
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Small Vessel Sub-trial
Status: Enrolling
Updated: 12/31/1969
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Small Vessel Sub-trial
Status: Enrolling
Updated:  12/31/1969
St. Johns Hospital
mi
from
Springfield, IL
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Small Vessel Sub-trial
Status: Enrolling
Updated: 12/31/1969
St. Johns Hospital
mi
from
Springfield, IL
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Small Vessel Sub-trial
Status: Enrolling
Updated:  12/31/1969
Jewish Hospital & St. Mary's Healthcare
mi
from
Louisville, KY
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Small Vessel Sub-trial
Status: Enrolling
Updated: 12/31/1969
Jewish Hospital & St. Mary's Healthcare
mi
from
Louisville, KY
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Small Vessel Sub-trial
Status: Enrolling
Updated:  12/31/1969
Northern Michigan Hospital
mi
from
Petoskey, MI
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Small Vessel Sub-trial
Status: Enrolling
Updated: 12/31/1969
Northern Michigan Hospital
mi
from
Petoskey, MI
Click here to add this to my saved trials